Literature DB >> 6227275

Is "subcortical dementia" a recognizable clinical entity?

R Mayeux, Y Stern, J Rosen, F Benson.   

Abstract

The concept of "subcortical dementia" is controversial, lacking clinical validation and having only a questionable pathological basis. Over 100 patients with Alzheimer's, Parkinson's or Huntington's disease, subdivided into three functional disability stages, were given a brief quantitative neuropsychological assessment. Patients with Huntington's or Parkinson's disease were less intellectually impaired than those with Alzheimer's disease at each functional stage. Criteria for dementia were present in all of the Alzheimer's patients but in only half of the Huntington's and Parkinson's disease groups. Patients with similar overall intellectual function scores had no distinct pattern of neuropsychological test performance. Depression, absent in patients with Alzheimer's disease, was present in half the patients with Huntington's and Parkinson's disease and was correlated with intellectual decline. The concept of subcortical dementia is misleading. The pattern of neuropsychological impairment is not distinct, and the neuropathological basis of dementia in these diseases may result from a combination of cortical and subcortical degeneration.

Entities:  

Mesh:

Year:  1983        PMID: 6227275     DOI: 10.1002/ana.410140305

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  21 in total

1.  A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.

Authors:  M O Habert; U Spampinato; J L Mas; M L Piketty; M C Bourdel; J de Recondo; P Rondot; S Askienazy
Journal:  Eur J Nucl Med       Date:  1991

2.  Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease.

Authors:  I Litvan; E Mohr; J Williams; C Gomez; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

3.  A forward application of age associated gray and white matter networks.

Authors:  Adam M Brickman; Christian Habeck; Marco A Ramos; Nikolaos Scarmeas; Yaakov Stern
Journal:  Hum Brain Mapp       Date:  2008-10       Impact factor: 5.038

Review 4.  Cognitive dysfunctions in multiple sclerosis--a "multiple disconnection syndrome"?

Authors:  Pasquale Calabrese; Iris Katharina Penner
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

Review 5.  Neuropsychological aspects of Parkinson's disease.

Authors:  S A Raskin; J C Borod; J Tweedy
Journal:  Neuropsychol Rev       Date:  1990-09       Impact factor: 7.444

6.  Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.

Authors:  G Lennox; J Lowe; M Landon; E J Byrne; R J Mayer; R B Godwin-Austen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-11       Impact factor: 10.154

7.  The cerebral localization of neuropsychological impairment in Alzheimer's disease: a SPECT study.

Authors:  G Goldenberg; I Podreka; E Suess; L Deecke
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

Review 8.  Parkinson's disease in 1984: an update.

Authors:  A E Lang; R D Blair
Journal:  Can Med Assoc J       Date:  1984-11-01       Impact factor: 8.262

9.  Depression in patients with dementia of Alzheimer type.

Authors:  E C Shuttleworth; S J Huber; G W Paulson
Journal:  J Natl Med Assoc       Date:  1987-07       Impact factor: 1.798

10.  Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization.

Authors:  S J Wang; R S Liu; H C Liu; K N Lin; D E Shan; K K Liao; J L Fuh; L S Lee
Journal:  Eur J Nucl Med       Date:  1993-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.